ChemoCommunity

Characterizing chemoresponse communities at transcriptional and post-transcriptional levels.

Compound Details

The detailed records of NSC 606497 were elucidated in the following 4 sections: 1) Basis: basic information about NSC 606497; 2) Community: the network communities that were significantly associated with the response to NSC 606497; 3) Molecule: the relationships between components within communities and NSC 606497; 4) MDR: the compounds that were significantly associated with the NSC 606497.

NSC Compound Enrichment Correlation
NSC 341936 Adenosine, 2-bromo-2'-deoxy- 0.0164116791870036 0.53508663
NSC 357704 Cyanomorpholinodoxorubicin 0.0164116791870036 0.72853246
NSC 606172 Camptothecin Derivative 0.0164116791870036 0.88512572
NSC 621486 2-Propen-1-one, 1-(1,4-dioxo-2,6,7-trimethylquinoxalin- 3-yl)-3-(2-nitrophenyl)- 0.0193573267900279 0.09665784
NSC 751382 N-(3-((2,5-dimethylbenzyl)oxy)-4-(N-methylmethylsulfonamido)phenyl)-2,3-dihydro-1H-indene-5-carboxamide 0.0193573267900279 0.15262869
NSC 26040 1-Piperidineethanol, .alpha.-[p-(p-chlorostyryl)phenyl]- 0.0193573267900282 -0.19232155
NSC 679795 Null 0.020946768375828 0.1358085
NSC 100290 Doxypyrromycin hydrochloride 0.0209467683758286 0.40257026
NSC 244714 Benzoic acid, 3,5-dinitro-2-(1H-purin-6-ylthio)-, ethyl ester 0.0209467683758286 0.15200587
NSC 327182 L-Glutamic acid, N-[4-[[(2-amino-1,4-dihydro-4-oxo-6-quinazolinyl)methyl]-2-propynylamino]benzoyl]- 0.0209467683758286 0.3972884
Total:67  Current:28    [First] [Prev] [Next] [Last]